The company has not filed an annual or quarterly report since its Q3 FY2022 10-Q, filed Nov 10, 2022. Its latest SEC filing is a SC 13G/A from Feb 14, 2023.
10-Q for Q3 FY2022, filed Nov 10, 2022
The sections below describe the company as of the FY2021 annual report.
Seeks a merger or similar combination with a business, focusing on healthcare and biotechnology targets.
10-K for FY2021, filed Mar 18, 2022
No revenue was reported.
10-K for FY2021, filed Mar 18, 2022
10-Q for Q3 FY2022, filed Nov 10, 2022
$486.8KView ↗
8-K, filed Nov 28, 2022
Las Vegas, NV, November 28, 2022 – Research Alliance Corp. II (the “Company”) (NASDAQ: RACB), a special purpose acquisition company, today…View ↗
Loading...